Clovis Oncology reported $-67397000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Anika Therapeutics ANIK:US $ 1.25M 7.88M
Arrowhead Research ARWR:US $ -63.37M 33.45M
AstraZeneca AZN:LN 1954M 415M
Clovis Oncology CLVS:US $ -67.4M 0.95M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Enanta Pharmaceuticals ENTA:US $ -33.39M 0.01M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Five Prime Therapeutics FPRX:US $ -20.85M 0M
Halozyme Therapeutics HALO:US $ 74.11M 17.41M
Insmed INSM:US $ -115292000 1.41M
Intrexon XON:US $ -29.88M 9.76M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NOVN:VX SF 4544M 120M
Puma Biotechnology PBYI:US $ -20.14M 15.04M
Rigel Pharmaceuticals RIGL:US $ -21.09M 6.3M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M
Veracyte VCYT:US $ -15.48M 24.67M